Clinical Trials Browser

OTHER × Interventional × Mast Cell Activation Disorders × Clear all

NCT04978740 2022-12-01

Ocular and Palpebral Manifestations of Mastocytosis (MOOMA)

Phase NA Completed

Mast Cell Activation Syndrome, Mast Cell Activation Disorders, Urticaria Pigmentosa

NCT01297777 2016-08-29

Imatinib in KIT-negative Systemic Mastocytosis

Phase 4 Completed

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic

NCT01602939 2016-08-29

Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis

Phase 2/3 Unknown

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic